Table 4: Patients who experienced adverse events that led to premature discontinuation from the study.

SubjectAge/sexEventSeverityCausality

FCM
128/FInjection site reactionGrade 2Probable
256/MSystemic inflammatory response syndromeGrade 3Probable
376/MDeathGrade 5Unlikely
453/MColon cancer recurrentGrade 4None

DEX
181/MDyspneaGrade 4Probable
219/FAbdominal painGrade 1Probable
329/FHypersensitivityGrade 2Probable
421/FHypersensitivityGrade 2Probable
557/FHypersensitivityGrade 2Probable
645/MHypersensitivityGrade 3Probable
737/FPeripheral edemaGrade 3Probable
832/FHypersensitivityGrade 4Probable
918/FDyspneaGrade 1Probable
1064/FAnaphylactic reactionGrade 4Probable
1120/FHypersensitivityGrade 3Probable